Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Ligand Pharmaceuticals Incorporated patents (2017 archive)

Recent patent applications related to Ligand Pharmaceuticals Incorporated. Ligand Pharmaceuticals Incorporated is listed as an Agent/Assignee. Note: Ligand Pharmaceuticals Incorporated may have other listings under different names/spellings. We're not affiliated with Ligand Pharmaceuticals Incorporated, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "L" | Ligand Pharmaceuticals Incorporated-related inventors

Method for treating disorders associated with glomerular function

Methods of administering and pharmaceutical compositions of a biphenyl sulfonamide compound which is a dual angiotensin and endothelin receptor antagonist are disclosed for treating diseases.. . ... Ligand Pharmaceuticals Incorporated

Derivatives of uridine 5'-cyclophosphate useful to treat hepatitis c viral infections

Some embodiments of the present invention include nucleoside 5′-monophosphate derivative compounds, their preparation and their uses. In some embodiments, such compounds are useful to treat hepatitis c viral infections.. ... Ligand Pharmaceuticals Incorporated

Selective androgen receptor modulators (sarms) and uses thereof

Provided herein are compounds that bind to androgen receptors and/or modulate activity of androgen receptors. Also provided are methods for making and using such compounds. ... Ligand Pharmaceuticals Incorporated

Glucagon antagonists

Provided herein are compounds, including enantiomerically pure forms thereof, and pharmaceutically acceptable salts or co-crystals and prodrugs thereof which have glucagon receptor antagonist or inverse agonist activity. Further, provided herein are pharmaceutical compositions comprising the same as well as methods of treating, preventing, delaying the time to onset or reducing the risk for the development or progression of a disease or condition for which one or more glucagon receptor antagonist is indicated, including type i and ii diabetes, insulin resistance and hyperglycemia. ... Ligand Pharmaceuticals Incorporated

Polynucleotides encoding rodent antibodies with human idiotypes and animals comprising same

The invention relates to polynucleotides, particularly chimeric polynucleotides useful for optimal production of functional immunoglobulins with human idiotypes in rodents. The invention further relates to rodents comprising such polynucleotides.. ... Ligand Pharmaceuticals Incorporated

Prodrug compounds and uses therof

Provided herein are cyclic phosphorus-containing prodrug compounds, their preparation and their uses, such as treating diseases via modulating molecular targets in the liver.. . ... Ligand Pharmaceuticals Incorporated

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Ligand Pharmaceuticals Incorporated in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Ligand Pharmaceuticals Incorporated with additional patents listed. Browse our Agent directory for other possible listings. Page by